×
Hero Background

Type 2 Diabetes Mellitus Treatment Companies

ID: MRFR/Pharma/4214-HCR
85 Pages
Rahul Gotadki
October 2025

Companies involved in the treatment of Type 2 Diabetes Mellitus (T2DM) cover a broad spectrum, including pharmaceuticals, medical devices, and healthcare services.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Type 2 Diabetes Mellitus Treatment Market Research Report - Forecast to 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Type 2 Diabetes Mellitus Treatment Market

Type 2 Diabetes Mellitus Treatment Key Companies

 

Latest Type 2 Diabetes Mellitus Treatment Companies Update


Eli Lilly Announced positive Phase 3 trial results for its GLP-1 receptor agonist Tirzepatide, demonstrating superior blood sugar control and weight loss compared to existing drugs.


Novo Nordisk Received FDA approval for its dual SGLT2/GLP-1 agonist Ozempic®, offering a new option for patients with inadequate glycemic control on other medications.


Boehringer Ingelheim Partnered with Eli Lilly to co-develop and commercialize their next-generation SGLT2 inhibitor Jardiance®, aiming to expand their reach in the diabetes market.


List of Type 2 Diabetes Mellitus Treatment Key Companies in the Market



  • Abbott Laboratories

  • Acon Laboratories Inc.

  • Adocia

  • Akros Pharma

  • Amgen

  • AstraZeneca

  • Bayer AG

  • Becton

  • Dickinson and Company

  • Biocon

  • Boehringer Ingelheim

  • Daiichi Sankyo

  • Eli Lilly

  • Merck

  • Novartis & Co.

  • Novo Nordisk

  • Peptron

  • Pfizer

  • Roche Diagnostics Ltd.

  • Sanofi

  • Sunpharma

  • Takeda Pharmaceuticals